Nautilus Biotechnology, Inc. (NAUT) Social Stream
NAUTILUS BIOTECHNOLOGY INC (NAUT) Price Targets From Analysts
Use the tables below to see what analysts covering NAUTILUS BIOTECHNOLOGY INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 2 | $13 | $13 | $13 | $3.05 | 326.23% |
| 2022-02-24 | 3 | $13 | $8 | $10.5 | $3.05 | 244.26% |
| 2022-05-04 | 3 | $11 | $8 | $9.5 | $3.05 | 211.48% |
| 2022-07-14 | 3 | $11 | $4 | $7.666 | $3.05 | 151.34% |
| 2022-08-03 | 4 | $11 | $4 | $7 | $3.05 | 129.51% |
| 2022-11-02 | 2 | $7 | $2 | $5 | $3.05 | 63.93% |
| 2023-02-24 | 3 | $7 | $2 | $5 | $3.05 | 63.93% |
| 2023-08-02 | 4 | $7 | $2 | $5 | $3.05 | 63.93% |
| 2023-11-07 | 4 | $6 | $3 | $5 | $3.05 | 63.93% |
The Trend in the Analyst Price Target
Over the past 20 months, NAUT's average price target has gone down $3.5.
NAUT reports an average of 118.78% for its upside potential over the past 37 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-24 | 3 | 7 | 2 | 5 | 1.790 | 179.33% |
| 2023-05-02 | 4 | 7 | 2 | 5 | 2.270 | 120.26% |
| 2023-08-03 | 3 | 6 | 6 | 6 | 3.140 | 91.08% |
| 2023-11-07 | 4 | 6 | 3 | 5 | 2.585 | 93.42% |
| 2023-11-07 | 3 | 6 | 6 | 6 | 2.585 | 132.11% |
NAUT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 20 months, NAUT's average broker recommendation rating worsened by 0.33.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- NAUT has a higher average analyst price target than 77.5% of all US stocks.
- NAUTILUS BIOTECHNOLOGY INC's number of analysts covering the stock is greater than 96% of all US stocks.
- In terms of how NAUTILUS BIOTECHNOLOGY INC fares relative to Measuring and Control Equipment stocks, note that its variance in analysts' estimates is lower than -547.12% of that group.
- To contextualize these metrics, consider that out of Measuring and Control Equipment stocks, NAUTILUS BIOTECHNOLOGY INC's upside potential (average analyst target price relative to current price) is higher than 934.55% of them.
Stocks similar to NAUTILUS BIOTECHNOLOGY INC in the Measuring and Control Equipment industry regarding analyst recommendations and price targets are INTT, DAIO, and FEIM.
View All Top Stocks by Price Target
Is NAUT a Buy, Hold or Sell? See the POWR Ratings now!